Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
education to enable regions to expand quickly and sustainably. In fact, the future is made here. NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine
-
clinical setting. We will use the gene editing technologies for the benefit of the patients in the Nordic hospitals. NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership
-
for the benefit of the patients in the Nordic hospitals. NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national
-
Postdoc in CRISPR Meta-Analytics and AI for Therapeutic Target Discovery and Priotisation (OT Grant)
cancers and other diseases. Together with researchers at EMBL – European Bioinformatics Institute and Wellcome Sanger Institute , our lab has recently been awarded an Open Targets Research Grant funding
-
Coding experience in Matlab, Python or R Record of high-quality first-author publications or preprints Success in competitive funding schemes/awards Who we are NORPOD is a collaborative postdoctoral
-
Boards and you will oversee communication of our research internally and externally. You will support and implement research initiatives, including a joint postdoctoral programme of the Nordic EMBL
-
for Systems Biomedicine (LCSB):Postdoctoral researcher focusing on the infective competence of the human microbiome in health and disease. AREA: Computational and experimental study of gut microbiome-borne
-
/ILL/EMBL/IBS), the structural biology institute (IBS) is a leading national and international research institute in the field of integrated structural biology. The IBS is a research center, a technical
-
and for broad societal impact. As the first historic partner of the European Molecular Biology Laboratory (EMBL) , the Michael Sars Centre is rooted in the Bergen academic community and serves as a
-
to be recruited will also be affiliated with the Laboratory for Molecular Infection Medicine Sweden (MIMS), a part of the Nordic EMBL Partnership for Molecular Medicine, and the Umeå Centre for Microbial